US Patent 10278923 | Patents | Expiry | Expiration | Dates

NOVO

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Denmark Flag Denmark

Post An Enquiry

Virtual Booth

SEMAGLUTIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10278923

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2034-05-02

Patent Use Code

U-2628

Delist Requested

Application Number

213051

Patent Use Description

Product Number

3

NOVO

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Denmark Flag Denmark

Post An Enquiry

Virtual Booth

SEMAGLUTIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10278923

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2034-05-02

Patent Use Code

U-2628

Delist Requested

Application Number

213051

Patent Use Description

Product Number

2

NOVO

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Denmark Flag Denmark

Post An Enquiry

Virtual Booth

SEMAGLUTIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10278923

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2034-05-02

Patent Use Code

U-2628

Delist Requested

Application Number

213051

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10278923

Novo Nordisk AS

NOVO

SEMAGLUTIDE

10278923

2034-05-02

U-2628

213051

3

NOVO

SEMAGLUTIDE

10278923

2034-05-02

U-2628

213051

2

NOVO

SEMAGLUTIDE

10278923

2034-05-02

U-2628

213051

1